According to the previous evidence, differentiating the type of BDNF transcripts (total or L-bdnf) and the precise place where changes in transcripts and protein levels occur in early postnatal age after embryonic VPA treatment may contribute to understanding the role of BDNF in the deviated neurodevelopmental trajectory of autism. The gene discussed is BDNF; the disease is autism.